Opinion: Businesses across the supply chain must work together to make Covid-19 vaccines

Published on:

As a scientist leading a company focused on RNA, I have cheered Pfizer, BioNTech, Moderna, and others as the biopharmaceutical industry raced to create vaccines that will end the tragic loss of life and the economic devastation wrought by Covid-19.

So far, two Covid-19 vaccines, one from Pfizer/BioNTech and one from Moderna, have been approved by the FDA under emergency use authorizations. Both are RNA-based vaccines that show strong efficacy and few side effects. Other vaccines, using other technologies, have been approved for use in other countries.

Read the rest…

Read more    Source: statnews.com